|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
08225 C HEALTH GP
Nominal 
0.160 0.000 (0.000%) | 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Turnover | 26,454 | 23.473% | 21,425 | 13,090 | 83,601 | 83,063 |
| Cost of Sales | (16,387) | 24.022% | (13,213) | (7,347) | (19,744) | -- |
| Gross Profit | 10,067 | 22.589% | 8,212 | 5,743 | 63,857 | -- |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | (381) | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | 18 | 15,585 | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | (14,473) | -75.137% | (58,211) | (15,826) | 42,521 | 70,796 | |
| Taxation | (46) | -- | 0 | 0 | (6,196) | (10,146) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 197 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (14,519) | -74.973% | (58,014) | (15,826) | 36,325 | 60,650 | |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (63) | -45.690% | (116) | (185) | (415) | 137 |
| Depreciation & Amortisation | 606 | 158.974% | 234 | 151 | 201 | 291 |
| Directors' Emoluments | -- | -- | 755 | 1,156 | 260 | 156 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Unqualified (Modified Report) | -- | Qualified | Qualified | Qualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | -1.460 | -74.957% | -5.830 | -1.590 | 3.650 | 6.100 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | 0.010 | -- | 0.001 | (0.005) | (0.010) | 0.019 |
| NBV per share ($) | 0.071 | -- | 0.085 | 0.143 | 0.156 | 0.119 |
| Remarks: | Real time quote last updated: 16/05/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -14,519,000 |
| %Change | -74.973% |
| EPS / (LPS) | RMB -0.015 |
| NBV Per Share (¥) | RMB 0.071 |